Published: 17 Apr. 2024
3 min
3 min read
0

Biotech company uses microbial fermentation process in carbon recycling technology

CustomerLife science researchMicrobial bioprocess

Zara Summers, Chief Science Officer at LanzaTech, a Biotech Company, vividly articulates the company goal to reduce fossil fuel consumption and instead, recycle carbon, that is already above ground to create necessities: "We want it so every child in the world can pick up a crayon and color the sky and have that crayon that they pick be blue. Right? And today that is not the reality for every kid around the world."

Zara Summers, Chief Science Officer at LanzaTech, a Biotech Company, vividly articulates the company's goal to reduce fossil fuel consumption and instead, recycle carbon, that is already above ground to create necessities.

We are proud to have supplied the INFORS HT Multifors bioreactors and eve® bioprocess platform software featured in the recent ABC7 Chicago article about LanzaTech's groundbreaking carbon recycling technology. The article highlights LanzaTech's innovative approach to reducing carbon emissions by capturing them from industrial sources and converting them into valuable products through microbial fermentation processes.

The Multifors Bioreactor stands out as an industry-leading product with our customer because it withstands the long running cycles required for their processes without any interruptions. The Multifors has a reliable magnetic drive system, capable of high RPM agitation for months at a time during extended continuous batches. This allows LanzaTech to increase their R&D productivity while maximizing their lab space efficiently.

The eve® bioprocess platform software further optimizes their R&D fermentation operations, connecting dozens of bioreactor systems to a web browser-based software platform across multiple lab spaces. Controlling, monitoring, and analyzing your bioprocess has never been easier and more efficient.

Our bioreactors and software play a crucial role in LanzaTech’s R&D work by providing the ideal environment for microbial fermentation for testing, optimizing, and prototyping. LanzaTech is continuously improving and optimizing its commercial process for converting captured carbon emissions into raw materials to produce a variety of useful products, including packaging, apparel, and fuels.

By supporting LanzaTech’s efforts, we’re not only helping to combat climate change by reducing carbon emissions, but we’re also effecting the development of a circular economy where waste is transformed into valuable resources.

Watch the full news report

Learn more about the products mentioned in this article

Multifors 2 Tischbioreaktor

Verwalten Sie mehrere Bioreaktorgefäße parallel und minimieren Sie gleichzeitig die Risiken beim Scale-up.

eve® Bioprozess Software Dienstleistungen

Individuelle Unterstützung für eine reibungslose Software-Performance durch unser Support-Team von eve®.

Services rund um unsere Bioreaktoren

Aufrechterhaltung optimaler Leistung und Langlebigkeit Ihrer Bioreaktoren

Multifors 2 Tischbioreaktor

Verwalten Sie mehrere Bioreaktorgefäße parallel und minimieren Sie gleichzeitig die Risiken beim Scale-up.

eve® Bioprozess Software Dienstleistungen

Individuelle Unterstützung für eine reibungslose Software-Performance durch unser Support-Team von eve®.

Services rund um unsere Bioreaktoren

Aufrechterhaltung optimaler Leistung und Langlebigkeit Ihrer Bioreaktoren

Did you like this article?Leave us a rating!

1
2
3
4
5
Average: 0/5

Comments(0)

In Verbindung stehende Artikel

Blog
04 Apr. 20256 min read0
60 stories for 60 years

A legacy of customer-centered excellence: For six decades, INFORS HT has built a legacy rooted in customer commitment, innovation, and lasting partnerships. To celebrate this milestone, we are sharing 60 Stories for 60 Years: a collection of inspiring stories from around the world that highlight the people and moments that define INFORS HT. Explore stories that showcase our people and culture, nemorable moments, growth and innovation, and customer successes, each reflecting our dedication to putting customers first. Join us in celebrating the relationships and breakthroughs that have shaped our journey.

12 Feb. 20259 min read10
Optimizing HEK293 cell cultures for gene therapy applications: the role of incubator flexibility

Gene therapy is a promising approach for treating various genetic disorders and diseases. A critical component of gene therapy is the production of viral vectors, which serve as delivery vehicles for therapeutic genes. Human Embryonic Kidney 293 (HEK293) cells have become a widely used platform for viral vector production due to their efficiency in transfection and ability to support viral replication. However, optimizing HEK293 cell cultures for large-scale production of viral vectors remains a challenge in making gene therapies more accessible and cost-effective.

06 Jan. 20254 min read10
Sustainable dairy innovation: Daisy Lab uses precision fermentation to produce animal-free milk proteins in INFORS HT bioreactors

As demand for sustainable food sources surges, Daisy Lab is revolutionizing dairy production with precision fermentation technology. By using INFORS HT bioreactors, this New Zealand-based startup is producing animal-free milk proteins like whey and casein. Discover how the innovative process at Daisy Labs, now set to scale with EPA approval, is paving the way for a more sustainable future in dairy.

04 Apr. 20256 min read0
60 stories for 60 years

A legacy of customer-centered excellence: For six decades, INFORS HT has built a legacy rooted in customer commitment, innovation, and lasting partnerships. To celebrate this milestone, we are sharing 60 Stories for 60 Years: a collection of inspiring stories from around the world that highlight the people and moments that define INFORS HT. Explore stories that showcase our people and culture, nemorable moments, growth and innovation, and customer successes, each reflecting our dedication to putting customers first. Join us in celebrating the relationships and breakthroughs that have shaped our journey.

12 Feb. 20259 min read10
Optimizing HEK293 cell cultures for gene therapy applications: the role of incubator flexibility

Gene therapy is a promising approach for treating various genetic disorders and diseases. A critical component of gene therapy is the production of viral vectors, which serve as delivery vehicles for therapeutic genes. Human Embryonic Kidney 293 (HEK293) cells have become a widely used platform for viral vector production due to their efficiency in transfection and ability to support viral replication. However, optimizing HEK293 cell cultures for large-scale production of viral vectors remains a challenge in making gene therapies more accessible and cost-effective.

06 Jan. 20254 min read10
Sustainable dairy innovation: Daisy Lab uses precision fermentation to produce animal-free milk proteins in INFORS HT bioreactors

As demand for sustainable food sources surges, Daisy Lab is revolutionizing dairy production with precision fermentation technology. By using INFORS HT bioreactors, this New Zealand-based startup is producing animal-free milk proteins like whey and casein. Discover how the innovative process at Daisy Labs, now set to scale with EPA approval, is paving the way for a more sustainable future in dairy.

Ihre Privatsphäre ist uns wichtig

Wir verwenden Cookies, um die Nutzererfahrung zu verbessern. Wir analysieren unseren Datenverkehr, wir personalisieren Inhalte und Anzeigen auf unserer Website und wir bieten Funktionen für soziale Medien. Bestimmte Cookies sind notwendig, damit unsere Website ordnungsgemäß funktioniert und Sie ihre Funktionen nutzen können. Mit Ihrer Zustimmung verwenden wir auch Analyse-Cookies zur Verbesserung unserer Website und Marketing-Cookies, um Werbung und Inhalte auf unserer Website anzuzeigen.
Cookie Einstellungen